Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yammy, Yung"'
Autor:
Harinder Gill, Radha Raghupathy, Carmen Y.Y. Lee, Yammy Yung, Hiu-Tung Chu, Michael Y. Ni, Xiao Xiao, Francis P. Flores, Rita Yim, Paul Lee, Lynn Chin, Vivian W.K. Li, Lester Au, Wing-Yan Au, Edmond S.K. Ma, Diwakar Mohan, Cyrus Rustam Kumana, Yok-Lam Kwong
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background The epidemiology and treatment of acute promyelocytic leukaemia (APL) are changing. We have incorporated oral arsenic trioxide (oral-ATO) into induction/maintenance. Methods Newly-diagnosed APL from 1991 to 2021 divided into three
Externí odkaz:
https://doaj.org/article/c6e19c5014b74121914b1a74c9edba0a
Autor:
Paul Lee, Rita Yim, Kai-Kei Miu, Sin-Hang Fung, Jason Jinyue Liao, Zhangting Wang, Jun Li, Yammy Yung, Hiu-Tung Chu, Pui-Kwan Yip, Emily Lee, Eric Tse, Yok-Lam Kwong, Harinder Gill
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 10, p 5670 (2022)
In myelodysplastic syndrome (MDS), resistance to hypomethylating agents (HMA) portends a poor prognosis, underscoring the importance of understanding the molecular mechanisms leading to HMA-resistance. In this study, P39 and Kasumi-1 cells and their
Externí odkaz:
https://doaj.org/article/242f13a9adea43ac815fe4e8db79d843
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 19, p 10232 (2021)
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and predisposition to acute myeloid leukemia (AML). Stem cell genomic instability, microenv
Externí odkaz:
https://doaj.org/article/49957e78d51d445c9d79e1480660006f
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2, p 659 (2021)
Myeloproliferative neoplasms (MPNs) are unique hematopoietic stem cell disorders sharing mutations that constitutively activate the signal-transduction pathways involved in haematopoiesis. They are characterized by stem cell-derived clonal myeloproli
Externí odkaz:
https://doaj.org/article/777ae3aa644041fc88e657a9a4cc6945
Autor:
Harinder Gill, Radha Ragupathy, Carmen Y.Y. Lee, Yammy Yung, Hiu-Tung Chu, Michael Ni, Xiao Xiao, Francis P Flores, Rita Yim, Paul Lee, Lynn Chin, Vivian W.K. Li, Lester Au, Wing-Yan Au, Edmond S.K. Ma, Diwakar Mohan, Cyrus R Kumana, Yok-Lam Kwong
BackgroundThe epidemiology and treatment of acute promyelocytic leukaemia (APL) are changing. We have incorporated oral arsenic trioxide (oral-ATO) into induction/maintenance.MethodsNewly-diagnosed APL from 1991 to 2021 divided into three 10-year per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02e0a4a7ed250df58f0692ee93e8a071
https://doi.org/10.21203/rs.3.rs-1610362/v1
https://doi.org/10.21203/rs.3.rs-1610362/v1
Autor:
Paul, Lee, Rita, Yim, Kai-Kei, Miu, Sin-Hang, Fung, Jason Jinyue, Liao, Zhangting, Wang, Jun, Li, Yammy, Yung, Hiu-Tung, Chu, Pui-Kwan, Yip, Emily, Lee, Eric, Tse, Yok-Lam, Kwong, Harinder, Gill
Publikováno v:
International journal of molecular sciences. 23(10)
In myelodysplastic syndrome (MDS), resistance to hypomethylating agents (HMA) portends a poor prognosis, underscoring the importance of understanding the molecular mechanisms leading to HMA-resistance. In this study, P39 and Kasumi-1 cells and their
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10232, p 10232 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and predisposition to acute myeloid leukemia (AML). Stem cell genomic instability, microenv
Autor:
Edmond S. K. Ma, Cyrus R. Kumana, Daniel Cheuk, Yok-Lam Kwong, Harinder Gill, Pui-Kwan Yip, Shau-Yin Ha, Hiu-Tung Chu, Rita Yim, Paul P. Lee, Emily Lee, Wing-Yan Au, Rock Y. Y. Leung, Yammy Yung
Publikováno v:
Blood Adv
Despite therapeutic advances, early death (ED) remains a major factor curtailing survival of acute promyelocytic leukemia (APL). Studies examining factors that cause early death (ED; within 30 days of admission) and the correlation of survival with t